I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 18% ± 2% | |
| natural killer cell | 6 studies | 19% ± 4% | |
| type I pneumocyte | 6 studies | 19% ± 4% | |
| classical monocyte | 4 studies | 22% ± 4% | |
| epithelial cell | 4 studies | 27% ± 8% | |
| ciliated cell | 4 studies | 20% ± 4% | |
| oligodendrocyte | 4 studies | 19% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 16% ± 0% | |
| GABAergic neuron | 3 studies | 38% ± 2% | |
| astrocyte | 3 studies | 20% ± 4% | |
| glutamatergic neuron | 3 studies | 45% ± 12% | |
| microglial cell | 3 studies | 26% ± 1% | |
| oligodendrocyte precursor cell | 3 studies | 21% ± 3% | |
| dendritic cell | 3 studies | 33% ± 12% | |
| macrophage | 3 studies | 18% ± 2% | |
| basal cell | 3 studies | 23% ± 1% | |
| plasmacytoid dendritic cell | 3 studies | 25% ± 3% |
